AI startup Safe Superintelligence’s $1 billion round — for a startup that’s existed for only a few months — easily led the way. However, it wasn’t just AI that got funding in September, as biotech makes up about half the list.
Business
The investment would be SoftBank’s first in OpenAI and comes more than a year after SoftBank founder Masayoshi Son told investors the fund would be...
This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. Series A commitments.
Through the middle of May, funding is less than half of what it was at the same point last year, per Crunchbase data, despite the war in Ukraine...
The startup industry has settled into a new, healthy normal where valuations have returned to reasonable levels, but will that lead us to a...
Bain Capital Ventures takes a research-first approach to investing in AI companies, Rak Garg, partner at the firm told us recently.
If the current sluggish pace of IPOs and acquisitions continues, it would take decades for every U.S. unicorn to generate an exit.
With IPOs still in a lull, funding flat and valuations down from their frothy highs, many have predicted an M&A boom is nigh. But Q1 saw just a...
High-quality diligence has returned, and it is both art and a science, writes guest columnist Nicolas Sauvage, who offers a look from both sides of...
Around 53% of investors surveyed predicted that 2024 will pick up in terms of investment pace compared to 2023, while 6% expect to do fewer deals.
Advisory boards can be a decisive competitive advantage for a company, but too often they fail to deliver on their potential. Kip Knight of Thomvest...
67.1K Followers